Alpha Crest Capital Management LLC Xencor Inc Transaction History

Alpha Crest Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$34.33 - $44.68 $377,630 - $491,480	-11,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$40.81 - $53.88 $448,910 - $592,680	11,000 New	11,000 $474,000
Q1 2020 May 13, 2020	SELL	$20.69 - $37.79 $531,464 - $970,711	-25,687 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$32.75 - $41.43 $349,999 - $442,762	10,687 Added 71.25%	25,687 $883,000
Q3 2019 Nov 12, 2019	BUY	$33.73 - $46.27 $505,949 - $694,050	15,000 New	15,000 $506,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.45B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.